Occult polymicrobial endocarditis with Haemophilus parainfluenzae in intravenous drug abusers. 1989

B Raucher, and J Dobkin, and L Mandel, and S Edberg, and M Levi, and M Miller
Department of Medicine, Montefiore Medical Center, Bronx, New York.

OBJECTIVE Fewer than 8 percent of intravenous drug abusers are found to have polymicrobial endocarditis. We report on cases of occult polymicrobial infective endocarditis with Haemophilus parainfluenzae in 10 intravenous drug abusers. Clinical and laboratory data on all 10 patients were obtained from hospital charts, and information on illicit drug use methods was given by five patients. Blood cultures were performed, as well as susceptibility testing to antibiotics. Subsequent molecular epidemiologic studies were performed on selected Staphylococcus aureus and H. parainfluenzae strains. Phage typing of S. aureus and biotyping of H. parainfluenzae strains were also done. RESULTS Results of the initial blood cultures were positive on the second to fifth days (mean, 2.6 days), demonstrating a gram-positive pathogen in nine patients and Bacteroides asaccharolyticus in one. Significantly, in each case, H. parainfluenzae alone was subsequently identified from additional blood cultures, with a mean delay of 20.4 days (range, five to 57 days) to the isolation of this organism. Epidemiologic data indicated that our cases did not represent a point-source outbreak. Antibiotic therapy uniformly failed until an agent active against H. parainfluenzae was added. The constellation of clinical, microbiologic, and epidemiologic findings was similar, and permitted prospective diagnosis and therapy in three patients. Despite the absence of S. aureus bacteremia in four, all 10 patients had right-sided endocarditis with septic pulmonary emboli. Five patients had initial blood cultures that were positive for two facultative gram-positive cocci (S. aureus and commensal oral streptococcal species). CONCLUSIONS Our findings suggest that polymicrobial endocarditis with H. parainfluenzae in intravenous drug abusers is a distinct clinical syndrome, and should be considered in all patients if the response to appropriate antibiotics is atypical or if pulmonary emboli continue with therapy.

UI MeSH Term Description Entries
D007275 Injections, Intravenous Injections made into a vein for therapeutic or experimental purposes. Intravenous Injections,Injection, Intravenous,Intravenous Injection
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D004697 Endocarditis, Bacterial Inflammation of the ENDOCARDIUM caused by BACTERIA that entered the bloodstream. The strains of bacteria vary with predisposing factors, such as CONGENITAL HEART DEFECTS; HEART VALVE DISEASES; HEART VALVE PROSTHESIS IMPLANTATION; or intravenous drug use. Bacterial Endocarditides,Bacterial Endocarditis,Endocarditides, Bacterial
D005260 Female Females
D006190 Haemophilus A genus of PASTEURELLACEAE that consists of several species occurring in animals and humans. Its organisms are described as gram-negative, facultatively anaerobic, coccobacillus or rod-shaped, and nonmotile. Hemophilus
D006192 Haemophilus Infections Infections with bacteria of the genus HAEMOPHILUS. Hemophilus Infections,Haemophilus influenzae Infection,Haemophilus influenzae Type b Infection,Hib Infection,Infections, Haemophilus,Infections, Hemophilus,Haemophilus Infection,Haemophilus influenzae Infections,Hemophilus Infection,Hib Infections,Infection, Haemophilus,Infection, Haemophilus influenzae,Infection, Hemophilus,Infection, Hib
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D013203 Staphylococcal Infections Infections with bacteria of the genus STAPHYLOCOCCUS. Infections, Staphylococcal,Staphylococcus aureus Infection,Staphylococcal Infection,Staphylococcus aureus Infections

Related Publications

B Raucher, and J Dobkin, and L Mandel, and S Edberg, and M Levi, and M Miller
October 1989, The American journal of medicine,
B Raucher, and J Dobkin, and L Mandel, and S Edberg, and M Levi, and M Miller
May 1998, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,
B Raucher, and J Dobkin, and L Mandel, and S Edberg, and M Levi, and M Miller
January 2005, Heart & lung : the journal of critical care,
B Raucher, and J Dobkin, and L Mandel, and S Edberg, and M Levi, and M Miller
January 2016, IDCases,
B Raucher, and J Dobkin, and L Mandel, and S Edberg, and M Levi, and M Miller
September 1993, The New Zealand medical journal,
B Raucher, and J Dobkin, and L Mandel, and S Edberg, and M Levi, and M Miller
February 1985, Medicina clinica,
B Raucher, and J Dobkin, and L Mandel, and S Edberg, and M Levi, and M Miller
November 1974, American journal of clinical pathology,
B Raucher, and J Dobkin, and L Mandel, and S Edberg, and M Levi, and M Miller
March 1987, Heart & lung : the journal of critical care,
B Raucher, and J Dobkin, and L Mandel, and S Edberg, and M Levi, and M Miller
June 1985, Medicina clinica,
B Raucher, and J Dobkin, and L Mandel, and S Edberg, and M Levi, and M Miller
August 1990, Emergency medicine clinics of North America,
Copied contents to your clipboard!